JPS6413025A - Antitumoral and manufacture - Google Patents
Antitumoral and manufactureInfo
- Publication number
- JPS6413025A JPS6413025A JP63134549A JP13454988A JPS6413025A JP S6413025 A JPS6413025 A JP S6413025A JP 63134549 A JP63134549 A JP 63134549A JP 13454988 A JP13454988 A JP 13454988A JP S6413025 A JPS6413025 A JP S6413025A
- Authority
- JP
- Japan
- Prior art keywords
- water
- amsa
- reconstruction
- pyroglutamic acid
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15678880A | 1980-06-12 | 1980-06-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6413025A true JPS6413025A (en) | 1989-01-17 |
| JPH0343251B2 JPH0343251B2 (ja) | 1991-07-01 |
Family
ID=22561097
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8702381A Granted JPS5728006A (en) | 1980-06-12 | 1981-06-08 | Antitumoral composition |
| JP63134549A Granted JPS6413025A (en) | 1980-06-12 | 1988-06-02 | Antitumoral and manufacture |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8702381A Granted JPS5728006A (en) | 1980-06-12 | 1981-06-08 | Antitumoral composition |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0042553B1 (ja) |
| JP (2) | JPS5728006A (ja) |
| AT (1) | ATE15602T1 (ja) |
| AU (1) | AU542346B2 (ja) |
| CA (1) | CA1188223A (ja) |
| DE (1) | DE3172317D1 (ja) |
| NZ (1) | NZ197116A (ja) |
| ZA (1) | ZA813866B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984001506A1 (en) * | 1982-10-13 | 1984-04-26 | Univ Birmingham | Pharmaceutical preparations for use in antitumour therapy |
| US4575509A (en) * | 1983-01-31 | 1986-03-11 | Bristol-Myers Company | Water-soluble formulations of m-AMSA with pyroglutamic acid |
| US4626541A (en) * | 1985-09-12 | 1986-12-02 | Bristol-Myers Company | Water soluble salt composition of m-AMSA |
| WO2020072948A1 (en) * | 2018-10-04 | 2020-04-09 | Race Oncology Ltd. | Method for preparing and delivering bisantrene formulations |
| CA3238360A1 (en) * | 2021-11-18 | 2023-05-25 | Steven M. Fruchtman | Methods and compositions for treating cancer |
| US20260183295A1 (en) * | 2022-11-17 | 2026-07-02 | Onconova Therapeutics, Inc. | Methods and compositions for treating cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010007871A (ja) * | 2008-06-24 | 2010-01-14 | Daikin Ind Ltd | 換気装置 |
-
1981
- 1981-05-15 NZ NZ197116A patent/NZ197116A/en unknown
- 1981-05-19 AU AU70837/81A patent/AU542346B2/en not_active Ceased
- 1981-05-22 CA CA000378081A patent/CA1188223A/en not_active Expired
- 1981-06-08 JP JP8702381A patent/JPS5728006A/ja active Granted
- 1981-06-09 ZA ZA00813866A patent/ZA813866B/xx unknown
- 1981-06-11 AT AT81104513T patent/ATE15602T1/de not_active IP Right Cessation
- 1981-06-11 EP EP81104513A patent/EP0042553B1/en not_active Expired
- 1981-06-11 DE DE8181104513T patent/DE3172317D1/de not_active Expired
-
1988
- 1988-06-02 JP JP63134549A patent/JPS6413025A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| EP0042553B1 (en) | 1985-09-18 |
| NZ197116A (en) | 1984-03-16 |
| EP0042553A1 (en) | 1981-12-30 |
| CA1188223A (en) | 1985-06-04 |
| JPH0343251B2 (ja) | 1991-07-01 |
| JPS5728006A (en) | 1982-02-15 |
| DE3172317D1 (en) | 1985-10-24 |
| ATE15602T1 (de) | 1985-10-15 |
| JPH0149693B2 (ja) | 1989-10-25 |
| ZA813866B (en) | 1982-06-30 |
| AU542346B2 (en) | 1985-02-21 |
| AU7083781A (en) | 1981-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE39517L (en) | Double salts of s-adenosyl-l-methionine | |
| KR950007855A (ko) | 정맥내 주사용 라파마이신 제형 | |
| GB1506197A (en) | Fluid in particular a hydraulic fluid comprising an antioxidant system | |
| GR3004869T3 (ja) | ||
| GB1317075A (en) | Purine nucleoside derivatives and a process for the manufacutre thereof | |
| JPS6434909A (en) | Cosmetic | |
| GB1440626A (ja) | ||
| GB1303392A (ja) | ||
| GB1188396A (en) | Treatment of Radioactive Liquids | |
| GB1497928A (en) | Immunoglobulin derivatives and process for the preparation thereof | |
| ES416403A1 (es) | Procedimiento de preparacion de polimeros con actividad an-tiinflamatoria. | |
| GB1438919A (en) | Compositions comprising chelated radioactive heave metals | |
| GR3004105T3 (ja) | ||
| ES486851A1 (es) | Un procedimiento de preparacion de acido 3a,7b-dihidroxico- lanico | |
| GB1270049A (en) | New pharmaceutical product | |
| GB1288835A (ja) | ||
| GB1229570A (ja) | ||
| GB1202120A (en) | A method of preparing comenic acid | |
| JPS5296721A (en) | Stable pharmaceutical dispersion | |
| FR2187312A1 (en) | Rapidly-soluble paracetamol - prepd by recrystallization from aqueous dioxan | |
| IL67411A0 (en) | Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it | |
| JPS51118000A (en) | Production of complex phosphoric acid | |
| JPS52140496A (en) | Production of nitrous oxide | |
| GB1415335A (en) | Polypeptides medicaments containing them and method for their manufacture | |
| JPS5283912A (en) | Fat emulsion for intravenous injection |